PharmTech News

Articles

The CDMO will be launching its EnzeneX 2.0 continuous manufacturing for biologics technology during CPHI Milan, which is being held Oct. 8–10, 2024 in Milan, Italy.

Enzene to Launch Continuous Manufacturing Technology at CPHI Milan 2024

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

The stand at booth 4A41, carried over from last year in Barcelona, will be constructed of white honeycomb cardboard and linoleum, with material waste generated during production repurposed into seats and tables.

ICE Pharma Touts Fully Recyclable Booth at Its CPHI Milan Exhibit

The group’s IMA Life division will present a robotic fill/finish solution that was awarded Best in Show at INTERPHEX 2023.

IMA Group Previews Its Showings Set for CPHI Milan

The company will be introducing its new low-substituted hydroxypropyl cellulose and its improved polyplasdone LN superdisintegrant at the October 2024 events.

Ashland to Exhibit Excipients at CPHI Milan and AAPS PharmSci 360

Feliza Mirasol is the science editor for 

As part of a range of sustainable products and services that SGD Pharma plans to showcase at CPHI Milan, the company will introduce its siliconized molded glass vials.

SGD Pharma to Introduce Siliconized Molded Glass Vials at CPHI Milan to Showcase Sustainable Packaging

The tubes are designed to provide an aluminum-free packaging solution for select pharmaceutical, dental, and ophthalmic products.

Neopac to Introduce New MMB Mini Tubes at CPHI Milan

The Almac Group is planning a £11 million (US$14.7 million) investment to expand the company’s existing analytical laboratories.

Almac Group Invests in Expansion of Analytical Services

According to the survey results, 49% of industry respondents are “highly positive” on the contract services sector seeing growth over the next 18 months.

Results from CPHI Milan Survey Find No Favor Among Industry for BIOSECURE Act While Predicting Faster Growth for CDMOs in 2025

The EcoPositive range, which comprises 50% of Bormioli Pharma’s current standard catalog and is composed of three distinct sustainability approaches, offers more than 3000 industrial solutions, in glass and plastic.

Bormioli Pharma Display at CPHI Milan to Include Low-Impact, Pharma-Grade Product Range

Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.

CPhI News